Tachyon Therapeutics

Tachyon Therapeutics

Biotechnology Research

San Francisco, CA 403 followers

Tachyon is advancing novel first-in-class compounds against significant new drug targets for treatments against cancer.

About us

Tachyon is accelerating innovative science to develop first-in-class therapeutics against significant new drug targets in cancer biology. Tachyon operates with a dedicated internal core development team and a world-class external network of expertise to achieve one goal - advance our programs with speed, innovation, quality and scientific integrity.

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
San Francisco, CA
Type
Privately Held
Founded
2020

Locations

Employees at Tachyon Therapeutics

Similar pages

Browse jobs

Funding

Tachyon Therapeutics 3 total rounds

Last Round

Series A

US$ 11.6M

See more info on crunchbase